233 related articles for article (PubMed ID: 38180827)
41. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M
J Virol; 2017 May; 91(10):. PubMed ID: 28275189
[TBL] [Abstract][Full Text] [Related]
42. Kaposi's Sarcoma-Associated Herpesvirus Hijacks RNA Polymerase II To Create a Viral Transcriptional Factory.
Chen CP; Lyu Y; Chuang F; Nakano K; Izumiya C; Jin D; Campbell M; Izumiya Y
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331082
[TBL] [Abstract][Full Text] [Related]
43. Demonstration of Kaposi's sarcoma-associated herpes virus cyclin D homolog in cutaneous Kaposi's sarcoma by colorimetric in situ hybridization using a catalyzed signal amplification system.
Reed JA; Nador RG; Spaulding D; Tani Y; Cesarman E; Knowles DM
Blood; 1998 May; 91(10):3825-32. PubMed ID: 9573020
[TBL] [Abstract][Full Text] [Related]
44. Kaposi's Sarcoma-Associated Herpesvirus-Encoded circRNAs Are Expressed in Infected Tumor Tissues and Are Incorporated into Virions.
Abere B; Li J; Zhou H; Toptan T; Moore PS; Chang Y
mBio; 2020 Jan; 11(1):. PubMed ID: 31911496
[TBL] [Abstract][Full Text] [Related]
45. Pathology of Kaposi's Sarcoma-Associated Herpesvirus Infection.
Fukumoto H; Kanno T; Hasegawa H; Katano H
Front Microbiol; 2011; 2():175. PubMed ID: 21904536
[TBL] [Abstract][Full Text] [Related]
46. Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo.
An FQ; Folarin HM; Compitello N; Roth J; Gerson SL; McCrae KR; Fakhari FD; Dittmer DP; Renne R
J Virol; 2006 May; 80(10):4833-46. PubMed ID: 16641275
[TBL] [Abstract][Full Text] [Related]
47. Kaposi's Sarcoma-Associated Herpesvirus LANA-Adjacent Regions with Distinct Functions in Episome Segregation or Maintenance.
Juillard F; De León Vázquez E; Tan M; Li S; Kaye KM
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626680
[TBL] [Abstract][Full Text] [Related]
48. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
49. Insight into the Epigenetics of Kaposi's Sarcoma-Associated Herpesvirus.
Srivastava A; Srivastava A; Singh RK
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834404
[TBL] [Abstract][Full Text] [Related]
50. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.
Viejo-Borbolla A; Schulz TF
AIDS Rev; 2003; 5(4):222-9. PubMed ID: 15012001
[TBL] [Abstract][Full Text] [Related]
51. A CRISPR-Cas9 screen identifies mitochondrial translation as an essential process in latent KSHV infection of human endothelial cells.
Holmes DL; Vogt DT; Lagunoff M
Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28384-28392. PubMed ID: 33122441
[TBL] [Abstract][Full Text] [Related]
52. Kaposi's Sarcoma Herpesvirus Genome Persistence.
Juillard F; Tan M; Li S; Kaye KM
Front Microbiol; 2016; 7():1149. PubMed ID: 27570517
[TBL] [Abstract][Full Text] [Related]
53. Sirtuin 6 Attenuates Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Suppressing Ori-Lyt Activity and Expression of RTA.
Hu M; Armstrong N; Seto E; Li W; Zhu F; Wang PC; Tang Q
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651359
[TBL] [Abstract][Full Text] [Related]
54. Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus.
Glenn M; Rainbow L; Auradé F; Davison A; Schulz TF
J Virol; 1999 Aug; 73(8):6953-63. PubMed ID: 10400794
[TBL] [Abstract][Full Text] [Related]
55. Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus.
Lu C; Zeng Y; Huang Z; Huang L; Qian C; Tang G; Qin D
Am J Pathol; 2005 Jan; 166(1):173-83. PubMed ID: 15632010
[TBL] [Abstract][Full Text] [Related]
56. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
Purushothaman P; Thakker S; Verma SC
J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
[TBL] [Abstract][Full Text] [Related]
57. Viral latent proteins as targets for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) induced lymphoma.
Staudt MR; Dittmer DP
Curr Drug Targets Infect Disord; 2003 Jun; 3(2):129-35. PubMed ID: 12769790
[TBL] [Abstract][Full Text] [Related]
58. Kaposi's Sarcoma-Associated Herpesvirus ORF21 Enhances the Phosphorylation of MEK and the Infectivity of Progeny Virus.
Yamaguchi T; Watanabe T; Iwaisako Y; Fujimuro M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674756
[TBL] [Abstract][Full Text] [Related]
59. Herpes simplex virus type 2 triggers reactivation of Kaposi's sarcoma-associated herpesvirus from latency and collaborates with HIV-1 Tat.
Tang Q; Qin D; Lv Z; Zhu X; Ma X; Yan Q; Zeng Y; Guo Y; Feng N; Lu C
PLoS One; 2012; 7(2):e31652. PubMed ID: 22347501
[TBL] [Abstract][Full Text] [Related]
60. The molecular pathology of Kaposi's sarcoma-associated herpesvirus.
Jenner RG; Boshoff C
Biochim Biophys Acta; 2002 Mar; 1602(1):1-22. PubMed ID: 11960692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
